...
机译:M1巨噬细胞衍生的纳米粒子强调了免疫检查点抑制剂的抗癌疗效
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Interdisciplinary Program Bioengn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Interdisciplinary Program Bioengn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
Seoul Natl Univ Interdisciplinary Program Bioengn Seoul 08826 South Korea;
Seoul Natl Univ Sch Chem &
Biol Engn Seoul 08826 South Korea;
cancer immunotherapy; checkpoint inhibitor; macrophage polarization; nanovesicle; tumor-associated macrophage;
机译:M1巨噬细胞衍生的纳米粒子强调了免疫检查点抑制剂的抗癌疗效
机译:以往的免疫检查点抑制剂治疗,增加多西紫杉醇和拉姆梭拉组合组合化疗的疗效术治疗免疫检查点抑制剂治疗,增加了多西紫杉醇和拉姆索姆拉姆联合化疗的疗效
机译:免疫检查点抑制剂根据患者年龄的抗癌疗效:系统审查和荟萃分析
机译:癌症治疗人酶免疫检查点抑制剂的工程与临床评价
机译:了解肾上腺素能应激信号如何影响抗肿瘤免疫应答以及检查点抑制剂在鼠肿瘤模型中的疗效
机译:M1巨噬细胞衍生的纳米寡粒子反对M2巨噬细胞抑制子宫内膜异位症的发展
机译:靶向脱胶克服了甘油免疫检查点,并提高了体内抗癌免疫反应